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1. Introduction
Over the counter (OTC) drugs in Japan are classified into three groups (I, II and III), based
on the safety [1]. Group I drugs have the highest risk of exerting the adverse effects on our
health. The intensity of such side effects declines in the order of Group I, II and III. Only
Group III drugs with the least side effects can be purchased through the internet.
Safety
Group I +
Group II ++ Kampo medicine, herb extracts
Group III +++ herb extracts, SE
Table 1. Classification of OTC drugs in Japan, based on the safety.
Kampo Medicines, classified as Group II, are usually available as hot water extracts of more
than two different plant species. Recently, the presentation of the detailed compositional
analysis by HPLC has become mandatory for the publication of the biological activity of
Kampo Medicines. However, we often experience the loss of biological activity of Kampo
medicines during the purification steps, thus making it difficult to assign the active princi‐
ples. Herb extracts are classified into Group II and Group III. Three major products of bam‐
© 2012 Sakagami et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
boo leaf extract (products A, B, C) are classified into Group III (Table 2), and other drugs are
classified into Group I.
Three major products of bamboo leaf extract
Product A (=SE) Fe (II)-chlorophyllin Pure Sasa senanensis Rehder extract
Product B Cu (II)-chlorophyllin LCC was removed
Product C Cu (II)-chlorophyllin Supplemented with ginseng and pine (Pinusdensiflora) leaf extracts.
Table 2. Three major products of Bamboo leaf extract available in the drug store in Japan.
Two bamboos, “Take” and “Sasa” (Japanese names) belong to grasses, but are not strictly
distinguished each other botanically. There are 70 genera of bamboos in the world and 14
genera (approximately 600 species) in Japan. Sasa culms are 1-2 m high, 5-8 mm in diameter,
robust, ramose at lower portions. Leaf-blades are oblong-lanceolate, 20-25 cm long and 4-5
cm broad (Figure 1A, B). They are distributed into Saghalien, the Kuriles, Hokkaido, Hon‐
shu, Shikoku and Kyushu in Japan. Product A (Sasa Health®, referred to as “SE”) (Figure
1C) is a pure alkaline extract of the leaves of Sasa senanensis Rehder (dry weight: 58.8 mg/ml
[2-4]) that contains Fe (II)-chlorophyllin, in which Mg (II) is replaced by Fe (II) by adding
FeCl2. SE-10 (Figure 1D) is a granulated powder of SE supplemented with lactose, lactitol,
trehalose and tea extract, and sold as dried and packaged powder in drug stores.
Products B (Sunchlon®, referred to as “BLE”) is an alkaline extract of Sasa Makino et Shibata
(dry weight 77.6 mg/ml [4]) that contains Cu (II)-chlorophyllin, but approximately 80% of
lignin-carbohydrate complex (LCC) has been removed as precipitate [5].
Product C (Shojusen®, referred to as “KS) is a hot water extract of the leaves of Sasa krilensis
Makino et Sibata (27.0 mg/ml), supplemented with ethanol extract of the leaves of Pinus den‐
siflora Sieb et Zucc. (1.2 mg/ml), ethanol extract of the roots of Panax ginseng C.A. Meyer
(0.92 mg/ml) and paraben as a preservative [6] (Table 2).
These bamboo leaf products is recognized as being effective in treating various malaises in‐
cluding fatigue, low appetite, halitosis, body odor and stomatitis [7-10]. However, there is
no scientific evidence that demonstrates their efficacy due to the lack of appropriate bio‐
markers, although their in vitro antiseptic [11], membrane stabilizing [12], anti-inflammatory
[13-16], phagocytic [17], radical scavenging [2, 4, 18, 19], anti-oxidant [20-23], antibacterial [2,
9], anti-viral [2, 4, 18, 19, 24] and antitumor activities [2, 25, 26] have been reported. SE
showed several common biological properties with LCCs, that is, the prominent anti-HIV,
anti-UV and synergistic activity with vitamin C [27, 28].
Lignins are major class of natural products present in the natural kingdom, and are formed
through phenolic oxidative coupling processes in the plant [29]. Lignins are formed by the
dehydrogenative polymerization of three monolignols: p-coumaryl, p-coniferyl and sinapyl
alcohols [29]. These monolignols were produced from L-phenylalanine by general phenyl‐
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propanoid pathway [30]. Some polysaccharides in the cell walls of lignified plants are linked
to lignin to form lignin-carbohydrate complexes (LCCs). Considering that both of SE and
LCC are prepared by extraction with alkaline solution, it is not surprising that they display
common biological activities with each other. Furthermore, we have recently identified the
anti-UV substances of SE as p-coumaric acid derivative(s), one of lignin precursors [31]. Al‐
kaline extraction step that is necessary for the preparation of SE provides higher amounts of
LCC as compared with hot-water extracted Kampo medicines. One or two-order higher an‐
ti-HIV activity of both SE and LCC over tannins and flavonoids suggest their possible ap‐
plicability towards virally-induced diseases.
However, there is a possibility that the components from SE and other plants are associated
with each other, thus modify their biological activities. Also, SE components may inhibit the
activity of CYP3A4, the most abundant drug-metabolizing enzyme, so as to increase the bio-
availability of co-administered drugs (especially, CYP3A4 substrates). Lastly, the clinical
evidences that demonstrate how the treatment of SE products improves the patient’s condi‐
tions are limited.
Based on these circumstances, we review the functional analysis of SE products as alterna‐
tive medicines, citing the literatures of other groups and ours, focusing on the following
points: (i) component analysis, (ii) spectrum of reported biological activities in comparison
with those of Kampo medicines, (iii) possibility of complex formation between the compo‐
A ＢB
C D
Figure 1. The primeval forest of Sasa senanensis Rehder (A), its leaves (B), SE (C) and SE-10 (D).
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nents, (iv) inhibition of CYP3A4 activity and (v) the clinical application for the treatment of
oral diseases.
2. Component analysis
Components of SE are listed in Table 3. Dietary fibre was the major component of SE. Water-
soluble and water-insoluble dietary fibres are present approximately at the 1: 2 ratio.
mg/100 ml mg/100 g* mg/100 ml mg/100 g*
Protein 1500 22700 Glycine
Lipid 200 3030 Proline 84 1270
Ash content 900 13600 Glutamic acid 186 2800
Sugar 1200 18200 Serine 21 320
Glucose 90 1360 Threonine 13 200
Arabinose 380 5700 Aspartic acid 159 2400
Xylose 1060 16000 Tryptophan 28 420
Galactose 180 2700
Dietary fibre 2100 31800 Folic acid 0.008 0.12
Water-soluble 1400 21200 Lutein 0.3 4.5
Water-insoluble 700 10600
Sodium 395 5980
Arginine 19 290 Iron 1.02 15
Lysine 59 890 Calcium 1.0 15
Histidine 23 350 Potassium 4.9 74
Phenylalanine 86 1300 Magnesium 0.5 8
Tyrosine 63 950 Zinc 0.08 1.2
Leucine 135 2040
Isoleucine 53 800 Vitamin A 0.003 0.05
Methionine 32 480 β-Carotene 0.032 0.5
Valine 95 1440 Vitamin K1 0.006 0.09
Alanine 105 1590 Glycine 99 1500
Table 3. Composition of SE. *corrected, assuming that 1 ml contains 66.1 mg SE. Cited from [19], with permission.
According to this information, we have fractionated the LCC into the following three frac‐
tions Fr I, II and III by repeated acid precipitation and solubization with NaHCO3 or NaOH
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solution, and polysaccharide fraction was recovered as Fr. IV by addition of equal volume of
ethanol in Figure 2.
 SE 50 mL  2.91 g (100 %)
10000 rpm,10 min,15  
Fr   Fr. III   
10000 rpm,10 min,15  
sup
extracted 25 mL of 1.39 % NaHCO3 or 1%NaOH 
10000 rpm,10 min,15  
pH                  5
AcOH
sup
Fr   
ppt
0.60± 0.28 g  
( 20.7 %)
10000 rpm,10 min,15  
ppt
AcOHpH                  5
0.59± 0.24 g
(20.2%)
pH  8.47
pH  6.31
ppt
sup
ppt
Fr. IV
sup
Figure 2. Fractionation of lignin-carbohydrate complex (LCC) fractions Fr I-III and polysaccharide fraction Fr IV. Yield of
Frs. I and II represents mean±S.D. from three independent experiments. Cited from [18], with permission
Luteolin glycosdes are isolated from the leaves of Sasa senanensis Rehder and their structures
were identified as decribed below (Figure 3) [32]. Luteolin 6-C-β-D-glucoside [compound 1]:
yellow amorphous powder, [α]25D +30.7˚ (c=0.12, CH3OH), mp 232˚ (dec.), ultraviolet (UV)
λmax (MeOH) nm (ε): 348 (22,200), 270 (17,600) and 258 (17,400). Electrospray ionization
time of flight mass spectra (ESI-TOF-MS) m/z: 448 ([M+H]+), high-resolution mass spectra
(HR-MS) m/z: 449.1094 (calcd. for C21H21O11, 449.1084).
Luteolin 7-O-β-D-glucoside [compound 2]:yellow amorphous powder, [α]25D -81.1˚ (c=0.10,
CH3OH), mp 261˚ (dec.), UV λmax (MeOH) nm (ε): 346 (20,500) and 270 (18,400). ESI-TOF-
MS m/z: 448 ([M+H]+), 287 ([aglycon+H]+), HR-MS m/z: 449.0976 (calcd. for C21H21O11,
449.1084).
Luteolin 6-C-α-L-arabinoside [compound 3]:yellow amorphous powder, [α]25D +66.0˚ (c=0.11,
CH3OH), mp > 300˚ (dec.), UV λmax (MeOH) nm (ε): 348 (22,100), 270 (17,600) and 258
(17,400). ESI-TOF-MS m/z: 419 ([M+H]+), HR-MS m/z: 419.1027 (calcd. for C20H19O10,
419.0978).
Tricin [compound 4]: yellow amorphous powder, UVλmax (MeOH) nm (ε): 349 (41,000) and
269 (27,200). ESI-TOF-MS m/z: 331 ([M+H]+): HR-MS m/z: 331.0837 (Calcd. for C17H15O7,
331.0818).
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Figure 3. Purification of luteolin 6-C-β-D-glucoside [compound 1], luteolin 7-O-β-D-glucoside [compound 2], luteolin
6-C-α-L-arabinoside [compound 3] and tricin [compound 4] from the leaves of Sasa senanensis Rehder. Cited from [32],
with permission.
We also isolated substances (SEE-1) that protected the cells from the UV-induced cytotoxici‐
ty, by ethanol extraction, Wakosil 40C18 chromatography (H2O elution) and preparative
HPLC (Shimadzu LC-10AD pump, Shimadzu SPD-M10AVP photodiode array detector, sep‐
aration column: Inatsil ODS-3, eluted with H2O : acetonitrile : formic acid (90:10:0.1), and
proposed the putative structures as p-coumaric acid derivative(s) (Figure 4) [31].
Figure 4. Identification of anti-UV substance(s) as p-coumaric acid derivative(s). Cited from [31] with permission.
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3. Biological activities
3.1. Antiviral activity
Anti-human immunodeficiency virus (HIV) activity was assessed quantitatively by a selec‐
tivity index (SI=CC50/EC50, where CC50 is the 50% cytotoxic concentration against mock-in‐
fected MT-4 cells, and EC50 is the 50% effective concentration against HIV-infected cells).
Products A, B and C all effectively and dose-dependently reduced the cytopathic effect of
HIV infection (closed symbols in Figure 5), although their anti-HIV activity was much lower
than that of positive controls [dextran sulfate (SI=1378), curdlan sulfate (SI=5606), azidothy‐
midine (SI=17746), 2’,3’-dideoxycytidine (SI=5123)] (Table 4). The potency of anti-HIV activi‐
ty was in the order of product A (Sasa-Health®, SE) (SI=607) > product C (SI=117) > product
B (SI=111) (Exp. I, Table 4) [4]. A granulated powder of Sasa senanensis Rehder leaf extract
(SE-10) (Figure 1D) (SI=54) showed slightly higher anti-HIV activity than SE (SI=45) (Exp. 2,
Table 4) [19]. Among the components of SE, LCC fractions prepared as described in Figure 3
(SI=37~62) showed comparable or slightly higher activity anti-HIV activity than unfractio‐
nated SE (SI=36) (Exp. 3, Table 4) [28]. Luteolin glycosides, luteolin 6-C-β-D-glucoside, luteo‐
lin 7-O-β-D-glucoside, luteolin 6-C-α-L-arabinoside and tricin from Sasa senanensis Rehder
leaf extract showed somewhat lower anti-HIV activity (SI=2~24) (Exp. 4, Table 4) [32]. The
anti-HIV activity of LCCs isolated from SE was comparable with that of LCCs from pine
cone, catuaba bark [33], cacao husk [34], cacao mass [35], cultured extract of Lentinus edodes
mycelia extract [36] and mulberry juice [37, 38], and synthetic lignin (dehydrogenation poly‐
mers of phenylpropanoids) [39], and was generally higher than that of tannins [40], flavo‐
noids [41], gallic acid, (-)-epigallocatechin 3-O-gallate (EGCG), curcumin, and chemically
modified glucans [42] (Exp. 5, Table 4) and Kampo medicines and its constituent plant ex‐
tracts [43] (Exp. 6, Table 4).
SE also protected the MDCK cells from the cytopathic effect of influenza virus infection
(CC50=0.67%, EC50=0.060%, SI=11) (Figure 6). Tricin showed potent anti-human cytomegalo‐
virus activity [24].
3.2. Anti-bacterial activity
Product B (BLE) significantly reduced the bacterial growth and lactate production in vitro in
the total saliva [9].
Product A (SE) showed a bacteriostatic, but not a bactericidal effect on Fusobacterium nuclea‐
tum and Prevotella intermedia (Figure 7A, 7B). The MIC50 for the Fusobacterium nucleatum and
Prevotella intermedia was calculated to be 0.63 and 1.25%, respectively, and at the highest
concentration (2.5%), 12.0 and 17.2% of the bacteria remained viable, respectively.
Gas chromatography demonstrated that these bacteria produced H2S and CH3SH, but not
(CH3)2H. SE more efficiently reduced the production of H2S in Fusobacterium nucleatum, with
a 50% inhibitory concentration (IC50) of 0.04% (Figure 7C). On the other hand, SE more effi‐
ciently reduced the production of CH3SH in Prevotella intermedia, with an IC50 of 0.16% (Fig‐
ure 7D). A higher concentration of SE (2.5%) completely eliminated both H2S and CH3SH [2].
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S I SI
Exp. 1 (Alkaline extract) Exp. 5 (other plant extracts)
Product A (SE) 607 LCC from pine trees (n=2) 27
Product B 111 LCC from pine seed shell 12
Product C 117 LCC from catuaba bark 43
Dextran sulfate 1378 LCC from cacao husk 311
Curdlan sulfate 5606 LCC from cacao mass 46
AZT 17746 LCC from cultured LEM 94
ddC 5123 LCC from mulberry juice 7
Exp. 2 (SE product) Phenylpropenoid polymers (n=23) 105
SE 45
SE-10 54 Neutral polysaccharide from pine cone 1
Dextran sulfate 160 N,N-dimethylaminoethyl paramylon <1
Curdlan sulfate 781 N,N-diethylaminoethyl paramylon <1
AZT 6931 N,N-dimethylaminoethyl curdlan <1
ddC 905 Hydrolyzable tannins monomer (n=21) <1
Hydrolyzable tannins dimer (n=39) <1
Exp. 3 (SE component) Hydrolyzable tannins trimer (n=4) 3
SE 36 Hydrolyzable tannins tetramer (n=3) 11
LCC Fr I (acid precipitation) 37 Condensed tannins (n=8) <1
LCC Fr II (acid precipitation ×2)) 58
LCC Fr III (acid precipitation × 2) 62 Flavonoids (n=160) <1
Polysaccharide fraction Fr IV ><1 Gallic acid <1
Butanol extract <1 (-)-Epigallocatechin 3-O-gallate <1
Curcumin <1
Exp. 4 (SE component) Chlorophyllin 5
SE 40
Luteolin 6-C-β-D-glucoside [1] >2 Exp. 6 (Plant extracts)
Luteolin 7-O-β-D-glucoside [2] 7 Kampo medicines (n=10) <1.0
Luteolin 6-C-α-L-arabinoside [3] >7 Constituent plant extracts (n=25) 1.3
Tricin [4] 24 AZT 17850
Table 4. Anti-HIV activity of polyphenols.
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Figure 5. Figure 1. Anti-HIV activity of three commercial products of Sasa senanensis Rehder extract. HIV-1IIIB-infected
(HIV+) and mock-infected (HIV–) MT-4 cells were incubated for 5 days with the indicated concentrations of products A
(upper panel), B (center panel) and C (lower panel) and the viable cell number was determined by the MTT assay and
expressed as a percentage that of the control. Data represent the mean±standard deviation from triplicate assays. It
should be noted that product C exhibited a weak cytostatic effect at lower concentrations (indicated by dotted circle).
Cited from [4], with permission.
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Figure 6. Anti-influenza virus activity of SE. Influenza virus-infected or mock-infected MDCK cells were incubated for 3
days with the indicated concentrations of SE, and the viable cell number was determined by MTT method. Each value
represents a mean from triplicate assays. Cited from [2] with permission.
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Figure 7. Antibacterial activity of SE. Fusobacterium nucleatum (A, C) and Prevotella intermedia (B, D) were cultured
anaerobically for 24 hours at 37oC with the indicated concentrations of SE in capped 15-cm centrifugation tubes. The
VSC released into the culture medium (black bar: H2S, white bar, CH3SH) was quantified by gas chromatography (C, D).
Bacterial growth was measured by recording the absorbance at 620 nm, using a microplate reader (A, B). (A, B) Bacter‐
iostatic activity of SE. Each point represents mean ±S.D. from triplicate assays. (C, D) Effect on VSC. Each bar represents
mean ±S.D. from triplicate assays. Without bar (0.02 and 0.04%SE (C), and 0.08 and 0.16% SE (D)) means the value
from a single assay. Cited from [2] with permission.
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3.3. Antitumor activity
Oral administration of SE (ad lib.) significantly delayed the development and growth of
mammary tumors in a mammary tumor strain of virgin SHN mice [25]. Oral administration
of SE (ad lib.) significantly inhibited spontaneous mammary tumorigenesis, reduced tumor
multiplicity, inhibited the mammary duct branching, side bud development and angiogene‐
sis in another mouse model of human breast cancer, transgenic FVB-Her2/NeuN mouse
model [26].
SE showed slightly higher cytotoxicity against the human squamous cell carcinoma cell lines
(HSC-2, HSC-3, HSC-4, Ca9-22, NA) (mean CC50=6.22%, 3.62 mg/mL) and the human glio‐
blastoma cell lines (T98G, U-87MG) (mean CC50=5.43%, 3.16 mg/mL), as compared with the
human oral normal cells [gingival fibroblast (HGF), pulp cell (HPC), periodontal ligament
fibroblast (HPLF)] (mean CC50=6.90%, 4.01 mg/mL), and was more cytotoxic to the human
myelogenous leukemic cell lines (HL-60, ML-1, KG-1) (CC50=1.18%, 0.68 mg/mL) and the hu‐
man T-cell leukemia cell line (MT-4) (CC50=1.41%, 0.82 mg/mL), with an approximate tumor
specificity index of 1.62 (Table 5). Although SE did not show high tumor-specific cytotoxici‐
ty, it was highly cytotoxic to three human myelogenous leukemic cell lines (HL-60, ML-1,
KG-1) and one T-cell leukemic cell line (MT-4). The type of cell death induced by SE remains
to be investigated [2].
3.4. Membrane stabilizing activity
In order to investigate whether SE contains membrane -stabilizing activity, SE was defatted
with hexane, and fractionated on Silica gel chromatography, according to the polarity, into
Fr. 1 (eluted with n-hexane: CH2Cl2), Fr. 2 (CH2Cl2), Fr. 3 (acetone), Frs 4 and 5 (methanol)
and Fr. 6 (residue). SE inhibited the hemolysis of rat red blood cells in hypotinic buffer by
13%. Frs. 3, 4 and 5 ihibited the homolysis approximately 35, 20 and 35%, respectively [12],
suggesting the membrane-stabilization activity of SE and its fractions.
Membrane stability can be evaluated by the extracellular leakage of glutamic-oxaloacetic
transaminase (GOT) and glutamic-pyruvic transamiase (GPT) from the hepatocytes. Control
hepatocytes released 85.1± 5.4 (mean±SD) K.U./ml GOT into the culture medium. SE (1~5
μi=60~300 μg/ml) significantly inhibited the release of GOT. Among the SE fractions, Frs. 1,
4 and 6 showed the inhibitory effects (Figure 8A). Control hepatocytes released 37.0 ±
3.6K.U./ml GPT inoto the culture medium. SE (1~2 μl=60, 120 μg/ml) significantly inhibited
the GTP release (Figure 8B) [13].
SE, Fr. 3 and Fr. 5 showed the surfactant action by reducing the surface tension. These sub‐
stances did not significantly affect the phase-transtion temperature of dipalmitoyl phospha‐
tidylcholine (DPPC)-liposome bilayer nor the membrane-fluidity. These data suggest that
the membrane-stabilizing activity of SE may be generated by polysaccharide, lignin, or
chlorophyll present in Fr. 3, 4 and 5.
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CC50
% (v/v) mg/mL
Human normal cells
Gingival fibroblast (HGF) 6.96 4.05
Pulp cell (HPC) 7.54 4.38
Periodontal ligament fibroblast (HPLF) 6.19 3.60
(mean) 6.90 4.01
Human oral squamous cell carcinoma cell lines
HSC-2 8.49 4.94
HSC-3 5.99 3.49
HSC-4 5.69 3.31
Ca9-22 4.20 2.44
NA 6.71 3.91
(mean) 6.22 3.62
Human glioblastoma cell lines
T98G 6.92 4.03
U87MG 3.94 2.29
(mean) 5.43 3.16
Human myelogenous leukemia cell lines
HL-60 1.14 0.66
ML-1 0.39 0.23
KG-1 2.00 1.16
(mean) 1.18 0.68
Human T-cell leukemia cell line
MT-4 1.41 0.82
TS value 1.62
The tumor-specificity index (TS) was measured by the following equation: TS= [CC50 (HGF) + CC50 (HPC) + CC50 (HPLF)] /
[CC50 (HSC-2) + CC50 (HSC-3) + CC50 (HSC-4) + CC50 (Ca9-22) + CC50 (NA) + CC50 (T98G) + CC50 (U87MG) + CC50 (HL-60) +
CC50 (ML-1) + CC50 (KG-1) + CC50 (MT-4)] x (11/3). Cited from [2] with permission.
Table 5. Cytotoxic activity of SE against human normal and tumor cells.
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Figure 8. Effect of SE and each fraction on the leakage of GOT (A) and GPT (B) from rat cultured hepatocytes. Hepato‐
cytes were suspended in Williams’ E medium for 24 h at 37ºC and culture was continued in the same medium with SE
or each fraction for 24 h at 37ºC. Each value was mean±S.D. of five experiments, and expressed as Karmen Units/ml of
medium. Values are significant: ∗p<0.05, ∗∗p<0.01, ∗∗∗p<0.001; control vs experiments (students t-test). Cited
from [13] with permission.
We next compared the hepatocyte protective effect of SE, other Herbal extracts and tinctures
(Aloe, Gambir, Swertiae, Plantaginis, Geranii, Houttuyniae extracts). Aloe extract rather en‐
hanced the leakage of liver enzymes, whereas SE and Gambir extract were inhibitory. SE
more significantly inhibited the enzyme leakage, as compared with other herbal extracts and
tinctures, suggesting that the hepatocyte protective activity of SE may be more potent that
other herbal extracts [13].
3.5. Anti-inflammatory activity
Oral administration of  hot water extract  of  leaves of  bamboo of  genus Sasa  spp (HSBE)
inhibited  the  carrageenan-induced  edema  and  12-O-tetradecanoylphorbol-13-acetate-in‐
duced  ear  swelling  in  mice,  possibly  by  inhibiting  the  production  of  proinflammatory
substances [prostaglandin E2 (PGE2), serotonin) and expression of 5-lipoxygenase, cycoox‐
ygenase-2  (COX-2),  tumor  necrosis  factor-α  (TNF-α),  interleukin-6  (IL-6)  and  IL-10.  Al‐
though  the  anti-inflammatory  activity  of  HSBE  was  much  less  than  that  of
dexamethasone, the major activity was concentrated into lower molecular weight, dialyz‐
able and methanol eluted fraction [16].
Single oral administration of SE (10~20 ml =0.6~1.2 mg/kg) slightly reduced the vasopermea‐
bility in ddY male mice (assessed by Whittle method). Single oral administration of SE (5
ml=0.3 mg/kg) slightly inhibited the formation of carrageenin-induced edema in SD male
rats at 1 h, but rather enhanced the formation of edema at 3 h and thereafter (Figure 9A).
Single oral administration of SE (5 ml=0.3 mg/kg) inhibited the formation of formalin-in‐
duced edema at 3 h (Figure 9B). Repeated oral administration of SE (1, 5, 10 ml/kg/day×7 or
9days) stimulated the growth of fibroblasts and neovascularization, in contrast to the en‐
hanced formation of collagen fiber. This suggests that SE may stimulate the regeneration of
normal tissue during the restoration process of inflammatory tissues [12].
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Oral administration of SE slightly increased the phagocytic index (assessed by carbon clear‐
ance method) after 3~5 h, but did not affect the phagocytic index at 7 days, suggesting that
SE does not reduce the function of reticuloendothelial system.
A B
Figure 9. Effect of SE on carrageenin (A) and formalin (B)-induced hind paw edema in rats.Each point represents the
mean of eight rats with S.D. ●---● : control, ●―――● : SE 1ml/kg, ■―――■ : SE 5 ml/kg,▲―――▲ : SE 10 ml/kg,.
∗,∗∗ : significantly different from the control value with p<0.05, p<0.01 (Student’s t-test). Cited from [12] with per‐
mission.
SE also inhibited the production of nitric oxide (NO) and prostaglandin E2 (PGE2) from the
LPS-activated mouse macrophage-like cells RAW264.7 via inhibition of the expression of
iNOS and COX-2 at protein and mRNA levels [14].
IL-1β induced one to two order higher production of proinflammatory substances (PGE2,
IL-6, IL-8, MCP-1), but not NO and TNFα by human gingival fibroblast (HGF). SE also in‐
hibited the production of IL-8 production by IL-1β-stimulated human gingival fibroblast
(Figure 10)[15].
3.6. Radical scavenging activity
ESR spectroscopy showed that SE (50%=29.1 mg/mL) did not produce any detectable ESR
signal at pH 7.4 (radical intensity (RI)<0.089) and pH 10.0 (RI<0.11). At pH 13.0, a weak
broad peak, similar to that of typical lignin [28], appeared (RI=0.14) [2].
Products A, B and C dose-dependently reduced the intensity of superoxide anion (O2–) (de‐
tected as DMPO-OOH) generated by hypoxanthine and xanthine oxidase reaction. The po‐
tency of O2– scavenging activity of the three products was comparable: product A (IC50=0.46
mg/ml), product B (IC50=0.52 mg/ml) and product C (IC50=0.54 mg/ml) (Table 6) [4].
Products A, B and C dose-dependently reduced the intensity of hydroxyl radical ( OH) (de‐
tected as DMPO-OH) generated by the Fenton reaction. The potency of products A and C
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was comparable with each other (IC50=2.1 and 1.9 mg/ml, respectively), but 4-fold higher
than that of product B (IC50=8.0 mg/ml) (Table 6) [4].
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Figure 10. SE inhibited the IL-1β-stimulated IL-8 production by HGF cells. HGF cells were incubated for 48 h with the
indicated concentrations of SE in the presence of IL-1β (1 ng/ml), and the extracellular IL-8 concentration (A) and via‐
ble cell number (B) were determined. mean± S.D (n=3). *<0.01. Cited from [15] with permission.
O2 ––Scavenging activity (IC50) ·OH–Scavenging activity (IC50)
Product A 0.69% (0.46 mg/ml) 3.2% (2.1 mg/ml)
Product B 0.67% (0.52 mg/ml) 10.3% (8.0 mg/ml)
Product C 1.9% (0.54 mg/ml) 6.6% (1.9 mg/ml)
Table 6. Radical scavenging activity of three commercial products of Sasa senanensis Rehder extract. Data was cited
from [2], with permission.
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3.7. Anti-UV activity
UV irradiation (6 J/m2/min) for 1 min followed by 48 h culture resulted in extensive cell
death (closed circles  in  Figure  11).  Popular  antioxidants,  N-acetyl-L-cysteine  (NAC) and
catalase  (enzyme that  degrades  hydrogen peroxide),  could  not  prevent  the  UV-induced
cellular  damage,  suggesting that  hydrogen peroxide may not  be involved in the UV-in‐
duced cytotoxicity, but the type of radical species produced by UV irradiation remains to
be identified (Exp. 1, Table 7). SE dose-dependently inhibited the UV-induced cytotoxici‐
ty in a bell-shaped fashion (Figure 11). The viability of the cells was recovered to 50% by
the addition of 0.53 mg/ml SE (=EC50). From the dose-response curve without UV irradia‐
tion, CC50 of SE was calculated to be 22.24 mg/ml. From these values, selectivity index SI
(CC50/EC50)  was calculated to be 41.96. Similar experiments were repeated three times to
yield the mean value of SI=19.7±15.1 (mean of four independent experiments) (Exp. I, Ta‐
ble  7).  The  ant-UV  activity  of  SE  was  slightly  less  than  that  of  sodium  ascorbate
(SI=30.2±13.4) (mean of five independent experiments), but higher than that of luteolin 6-
C-β-D-glucoside  [1]  (SI>8),  luteolin  7-O-β-D-glucoside  [2]  (SI>6),  luteolin  6-C-α-L-arabino‐
side  [3]  (SI>6),  Tricin  [4]  (TS>3),  gallic  acid  (SI=17.1),  EGCG  (SI=7.7),  chlorophyllin
(SI=0.53) and chlorophyll a (SI<0.24) (Exp. I, Table 7) [3].
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Figure 11. Anti-UV activity of SE. HSC-2 cells were treated without (○) or with UV (●) irradiation (6 J/m2/min) for 1
min in PBS(–) containing SE. Viable cell number determined by MTT method 48 h after irradiation, and expressed as
percent of control (without UV irradiation). EC50: 50% effective concentration, CC50: 50% cytotoxic concentra‐
tion.Mean ± S.D. of triplicate determinations. Cited from [3] with permission.
SE (product A) showed higher anti-UV activity (SI=20) than other Sasa senanensis Rehder leaf
products B (SI=4) (that has lower amounts of LCC) and C (SI=13) (that contains ginseng ex‐
tract and pine (Pinus densiflora) leaf extract) [4], suggesting the importance of LCC for the
anti-UV activity. A granulated powder of Sasa senanensis Rehder leaf extract (SE-10) (SI=129)
showed approximately three-fold higher anti-UV activity than SE (Exp. 2, Table 7)[19], sug‐
gesting some synergistic effect of SE and other components present in SE-10.
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LCCs from pine cones, pine seed and cultured LEM (SI=26-42) showed comparable anti-UV
activity with SE (SI=39). Lignin precursor, vanillin, showed higher anti-UV activity compa‐
rable with that of sodium ascorbate (SI=64) (Exp. 3, Table 7) [44, 45]. On the other hand,
chemically-modified glucans, such as N,N-dimethylaminoethyllaminarin, N,N-dimethylami‐
noethylpullulan, N,N-dimethylaminoethyldextran and paramylon sulfate (SI<1) [45] (Exp. 4,
Table 7), hot water extract (Kampo medicines and constituent plant extracts) [43] (SI=1~2)
(Exp. 5, Table 7) and tea extracts (green tea, black tea, oolong tea, burley tea, Jasmine tea)
[44] (Exp. 6, Table 7) were also inactive (SI=1~2). These data suggests the alkaline extracts
(such as SE and LCCs) show higher anti-UV activity than hot-water extracts (such as Kampo
medicines, tea extracts).
S I SI
Exp. 1 Exp. 3 (LCCs)
SE 20 LCC from pine cones (n=3) 33
Luteolin 6-C-β-D-glucoside [1] >8 LCC from pine seed 26
Luteolin 7-O-β-D-glucoside [2] >6 LCC from cultured LEM 42
Luteolin 6-C-α-L-arabinoside [3] >6 SE 39
Tricin [4] >3 Vanilline 64
Chlorophyllin <1 Sulfated lignin (n=2) >8
Chlorophyl a <1 Sodium acorbate 64
Sodium ascorbate 30 Exp. 4 (polysaccharides)
Gallic acid 17 N,N-Dimethylaminoethyllaminarin <1
EGCG 8 N,N-Dimethylaminoethylpullulan <1
Curcumin <1 N,N-Dimethylaminoethyldextran <1
Ar-turmerone <1 Paramylon sulfate <1
Sodium ascorbate 89
N-Acetyl-L-cysteine <1
Catalase <1 Exp. 5 (Plant extracts)
Kampo medicines (n=10) 2
Exp. 2 (SE products) Constituent plant extracts (n=25) 1
Product A (SE) 20
Product B (BLE) 4 Exp. 6 (Tea extract)
Product C (KS) 13 Green tea 3
Sodium acorbate 33 Black tea <1
Oolong tea <1
SE 39 Burley tea <1
SE-10 129 Jasmine tea <1
Sodium ascorbate 90 Sodium ascorbate 30
Table 7. Anti-UV activity of various natural products.
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3.8. Synergistic action with vitamin C
Vitamin C exhibited either antioxidant or prooxidant activity, depending on the concentra‐
tion [46]. We have reported that ascorbate derivatives that produced the doublet signal of
ascorbate radical (sodium-L-ascorbate, L-ascorbic acid, D-isoascorbic acid, 6-β-D-galactosyl-L-
ascorbate, sodium 5,6-benzylidene-L-ascorbate) induced apoptosis (characterized by internu‐
cleosomal DNA fragmentation and an increase in the intracellular Ca2+ concentration) in
HL-60 cells. On the other hand, ascorbate derivatives that did not produce radicals (L-ascor‐
bic acid-2-phosphate magnesium salt, L-ascorbic acid 2-sulfate and dehydroascorbic acid)
did not induce apoptosis [47, 48]. This suggests the possible involvement of the ascorbate
radical in apoptosis-induction by ascorbic acid-related compounds.
We accidentally found that LCCs from the pine cone of Pinus parviflola Sieb et Zucc, pine
cone of Pinus elliottii var. Elliotti, leaf of Ceriops decandra (Griff.) Ding Hou and, thorn apple
of Crataegu Cuneata Sieb. et Zucc modulated the radical intensity of ascorbate bi-phasically,
depending on the concentrations. At higher concentration, LCCs strongly enhanced the rad‐
ical intensity of sodium ascorbate, which rapidly decayed, possibly due to the breakdown of
ascorbic acid or to the consumption of ascorbyl radical. LCCs, not only from pine cones (Fr.
VI), but also from Catuaba bark, pine seed shell, A. nikoense Maxim. and C. Cuneata Sieb. et
Zucc. enhanced the radical intensity and cytotoxic activity of sodium ascorbate [27]. On the
other hand, tannins such as gallic acid, EGCG, and tannic acid counteracted the radical in‐
tensity and cytotoxic activity of sodium ascorbate [49].
Sodium ascorbate rapidly reduced the oxygen concentration in the culture medium, possi‐
bly due to oxygen consumption via its pro-oxidation action. Simultaneous addition of LCCs
further enhanced the ascorbate-stimulated consumption of oxygen [50]. These data suggest
that the synergistic enhancement of the cytotoxic activity of LCCs and ascorbate might be
due at least in part to the stimulated induction of hypoxia.
Lower concentration of LCC (pine cone Fr. VI) and sodium ascorbate showed radical scav‐
enging activity. LCC further stimulated the superoxide anion (O2-) and 1,1-diphenyl-2-pic‐
rylhydrazyl (DPPH) radical scavenging activity of sodium ascorbate. LCCs from Ceriops
decandra (Griff.) Ding Hou. and cacao husk scavenged O2- and hydroxyl radical, and synerg‐
istically enhanced the radical scavenging activity of sodium ascorbate [27, 34].
Similarly, SE and vitamin C synergistically enhanced the activity that scavenging superox‐
ide anion radical (determined by the intensity of DMPO-OOH) and hydroxyl radical (deter‐
mined by the intensity of DMPO-OH radical) (Table 8) [2].
DMPO-OOH radical intensity (% of
control) DMPO-OH radical intensity (% of control)
0.5% VC 0.25% + 5 μM VC 1% VC 0.5% + 5 μM VC
SE 48.3 47.1 < 60.4 [(48.3+72.4)/2] 65.4 75.5 < 87.3 [(65.4+109.1)/2]
10 μM vitamin C 72.4 109.1
Table 8. Synergistic radical scavenging activity of SE and vitamin C. Cited from [2] with permission.
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3.9. Inhibition of CYP3A4 activity
CYP3A4 activity was measured by β-hydroxylation of testosterone in human recombinant
CYP3A4. Products A, B and C dose-dependently inhibited the β-hydroxylation of testoster‐
one, generally used for the assay of CYP3A4 activity. Product C exhibited the highest
CYP3A4–inhibitory activity (IC50=58 μg/ml), followed by product B (IC50=124 μg/ml) and
then product A (IC50=403 μg/ml). Product B inhibited the CYP3A4 to an extent similar to that
attained by Cu (II)- chlorophyllin; product A inhibited CYP3A4 to lower extent than that
achieved by grapefruit juice (Figure 12) [4].
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Figure 12. CYP3A4 inhibitory activity of products A, B and C. One millilitre of products A, B and C was freeze dried to
produce the powder (66.1, 77.6 and 28.5 mg, respectively).Each value represents the mean ± S.D. (n=3). *p<0.05 rela‐
tive to the control (0%). Cited from [4] with permission.
SE-10 and SE dose-dependently inhibited the β-hydroxylation of testosterone, generally
used for the assay of CYP3A4 activity. SE-10 (IC50= 0.516 μg SE equivalent/ml) had an ap‐
proximately 16% lower CYP3A4-inhibitory activity (IC50= 0.445 μg/ml) [19].Combined with
our recent report [4], CYP3A4 inhibitory activity increases in the following order (from low‐
er to higher): SE-10 < SE < products B and C. SE-10 and SE seem likely to be safer drugs as
compared with products B and C, since the latter are expected to enhance the side-effects of
CYP3A4-metabolizable drugs more potently.
3.10. Possibility of complex formation between the components
Solvent fractionation of SE demonstrated that the majority of chlorophyllin and the activity
that inhibited the NO production by macrophages were recovered from the water layer that
contains majority of compounds (more than 81%) [18]. This suggests the possibility that
chlorophyllin in SE may be associated with hydrophilic substances, especially LCC in the
native state or after extraction with alkaline solution, since the preparative method of SE is
the same with that of LCC. This was supported by the observation that LCC isolated from
SE has greenish color (absorption peak = 655 nm), characteristic to chlorophyllin (absorption
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peak = 629 nm), expected to contain 1.7-2.6% chlorophyllin in the molecule, and that 68.5%
of SE eluted as a single peak at the retention time of 22.175 min in HPLC [18]. Upon binding
to chlorophyllin, LCC may obtain the activity of inhibiting the NO production by activated
macrophages.
3.11. Clinical application for the treatment of oral diseases
Oral intake of product B (BLE) slightly but significantly reduced the gingival crevicular fluid
(determined by Periometer®), and tended to reduce gingival index in the experimentally in‐
duced gingivitis patients [9].
Lichen planus is a chronic mucocutaneous disease that affects the skin, tongue, and oral mu‐
cosa. The most common presentation of oral lichen planus is the reticular form that mani‐
fests as white lacy streaks on the mucosa (known as Wickham's striae) or as smaller papules
(small raised areas). The cause of lichen planus is not known. Some lichen planus-type rash‐
es occur as allergic reactions to medications and a complication of chronic hepatitis C virus
infection [51]. Hepatitis C virus has been reported to occasionally replicate in oral lichen tis‐
sue and contribute to mucosal damage [52, 53]. It has been reported that the Epstein-Barr
virus is more frequently detected in oral lesions such as oral lichen planus and oral squa‐
mous cell carcinoma in comparison with healthy oral epithelium [54].
Potent antiviral, antibacterial, and anti-inflammatory activity of SE prompted us to investi‐
gate whether SE is effective on oral lichenoid dysplasia and osteoclastogenesis. A male pa‐
tient with white lacy streaks in the oral mucosa was orally administered SE three times a
day for ten months. Long-term treatment cycle of SE progressively reduced both the area of
white steaks (Figure 13) and the base-line levels of salivary interleukin-6 and 8 (Figure 14)
[55]. IL-8 concentration after SE treatment was below the initial level throughout the experi‐
mental period. This was accompanied by the improvement of patient’s symptoms. Before
the SE treatment, the patient felt that the mucosa is uneven, rough and cut by touching with
his tongue. Three weeks after the treatment, such feeling reduced and the mucosa became
much smooth. At four weeks, the rough mucosa was narrowed into smaller area, and the
patient could eat without pungent feeling on the oral mucosa. Oral intake of SE also im‐
proved the patient’s symptom of pollen allergy, and loose teeth, giving an impression that
the oral mucosa became much tighter. SE significantly inhibited the RANKL-induced differ‐
entiation of mouse macrophage-like RAW264.7 cells towards osteoclasts (evaluated by
TRAP-positive multinuclear cell formation). These pilot clinical study suggests the thera‐
peutic potentiality of SE against oral diseases [55].
4. Conclusion
SE (Sasa Health®), alkaline extract of Sasa senanensis Rehder extract has shown diverse bio‐
logical activities including membrane stabilizing, anti-leukemia, anti-inflammatory, radical
scavenging, anti-UV, bacteriostatic, antiviral, anti-stomatitis, and anti-lichen planus activity
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(Figure 15). Among these biological activities, antiviral, anti-UV and synergism with vita‐
min C are unique properties to SE as well as LCC (Figure 15).
Figure 13. Time-dependent effect of SE on the oral lichenoid dysplasia. One 51 years old male patient with lichenoid
dysplasia was treated for 0, 1 or 10 months with 13.3 ml of 50% diluted SE (containing 33 mg dried material/ml) at
each meal, 3 times a day. Intraoral photographs in the right side (upper panel) and left side (lower panel) of buccal
mucosa were taken. It should be noted that the SE treatment progressively reduced the area of the white streaks (a →
d → g, b → e → h in the right side of buccal mucosa and c → f → i in the left side of buccal mucosa). Cited from [55] with
permission.
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Figure 14. Effect of SE on saliva inflammatory cytokine level. One lichenoid dysplasia patient was treated with SE for
the indicated periods, and the salivary IL-6 and IL-8 concentrations were determined by ELISA. Each value represents
mean±S.D. of triplicate assays. ○: Control, ●:SE treatment. Cited from [55] with permission.
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Figure 15. Diverse biological activity of SE..
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SE as well as LCCs, which are efficiently extracted with alkaline solution, showed higher an‐
ti-HIV and anti-UV activity, as compared with hot water extract of many plant species in‐
cluding Kampo medicines (Figure 16). Antitumor activity of polysaccharide fractions of pine
cone extracts against ascites tumor cells transplanted in mice also increased with acidity
(binding strength to DEAE-cellulose column) [56], suggesting the potency of alkaline extract
against certain types of diseases.
Product C 
(KS)
Product A 
(SE)
LCC
Kampo
medicines
Acidity
Anti-tumor activity
Anti-HIV activity
Anti-UV activity
Product C
(BLE)
(LCC
depleted)
Hot water extract Alkaline extract
Figure 16. Comparison of several biological activities between hot water and alkaline extracts.
We have reported broad antiviral spectrum of LCC ranging from HIV [57-59], influenza vi‐
rus [60-62], herpes simplex virus [63-65]. Oral administration of LCC from pine cone extract
significantly improved the symptom of HSV-infected patients [66, 67], and lichenoid dyspla‐
sia patient [55]. These data suggest the possible application of SE to virally-induced diseas‐
es. Considering to low absorption through the intestinal tract [68], the application through
the mucosa membrane is recommended. We are now studying the interaction between SE,
antibacterial agent and charcoal to optimize the therapeutic potential of SE for the main
component of toothpaste.
LCC is composed of two major components: polysaccharide and phenylpropanoide polymer
[29, 30, 69, 70]. Limited digestion study demonstrated that anti-viral activity of LCC is gen‐
erated by its phenylpropanoid portion [58, 61], and immnopotentiation activity possibly by
polysaccharide. Using DNA microarray analysis, we have recently reported that treatment
of mouse macrophage-like J774.1 cells with LCC fractions isolated from LEM (Fr4) enhanced
the expression of dectin-2 (4.2-fold) and toll-like receptor (TLR)-2 (2.5-fold) prominently, but
only slightly modified the expression of dectin-1 (0.8-fold), complement receptor 3 (0.9-fold),
TLR1, 3, 4, 9 and 13 (0.8- to 1.7-fold), spleen tyrosine kinase (Syk)b, zeta-chain (TCR) associ‐
ated protein kinase 70kDa (Zap70), Janus tyrosine kinase (Jak)2 (1.0- to 1.2-fold), nuclear fac‐
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tor (Nf)кb1, NFкb2, reticuloendotheliosis viral oncogene homolog (Rel)a, Relb (1.0- to 1.6-
fold), Nfкbia, Nfкbib, Nfкbie, Nfкbi12 Nfкbiz (0.8- to 2.3-fold). On the other hand, LPS did
not affect the expression of dectin-2 nor TLR-2. These data suggest the significant role of the
activation of the dectin-2 signaling pathway in the action of LCC on macrophages [71]. It is
generally accepted that dectin- 2 is the receptor for mannan, whereas dectin-1 is that for glu‐
can [72-76]. It remains to be investigated the signaling pathway of LCC via dectin-2.
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